 |
|
Researchers test old drug with new hopes for pre-eclampsia cure
September 17, 2007GALVESTON, Texas - Researchers at the University of Texas Medical Branch at Galveston are trying to determine whether a drug already available to heart patients can also be used to delay delivery in expectant mothers with severe preeclampsia. If so, this groundbreaking study would give hope to hundreds of thousands of women who experience this life-threatening disorder each year.
The drug, Digibind, has been prescribed for over 20 years to patients who overdose on a certain heart medication, but is not yet approved for preeclampsia, the most common and dangerous pregnancy complication affecting as many as eight in every 100 pregnant women. The disorder is characterized by high blood pressure, protein in the urine and multi-organ dysfunction, all of which can seriously harm both mother and fetus.
"Preeclampsia is the No. 1 killer of pregnant women in the world, and there is no cure except delivery," said Dr. George Saade, chief of maternal-fetal medicine at UTMB. "When it is severe and occurs early in the pregnancy, delivery in order to protect the mother results in a premature baby. That's why this study is important, because if the medication works, then we can protect the mom while allowing the baby to grow and develop without delivering early."
The clinical trial will test whether Digibind reverses or prevents the abnormalities that occur with preeclampsia and allows the fetus to remain in the womb longer. This would give doctors more time to administer steroids to prevent respiratory complications in premature births and reduce the need for costly and lengthy neonatal intensive care.
"Right now, there is no treatment for preeclampsia, so this is truly groundbreaking," said Dr. Nicole Ruddock, the study's principal investigator and an instructor in UTMB's Department of Obstetrics and Gynecology.
University of Texas Medical Branch at Galveston
The clinical trial will test whether Digibind reverses or prevents the abnormalities that occur with preeclampsia and allows the fetus to remain in the womb longer. This would give doctors more time to administer steroids to prevent respiratory complications in premature births and reduce the need for costly and lengthy neonatal intensive care.
"Right now, there is no treatment for preeclampsia, so this is truly groundbreaking," said Dr. Nicole Ruddock, the study's principal investigator and an instructor in UTMB's Department of Obstetrics and Gynecology.
University of Texas Medical Branch at Galveston
Preeclampsia News and Current Preeclampsia Events RSSCommon treatment to delay labor decreases preterm infants' risk for cerebral palsy
Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine.
Maternal deaths following cesarean delivery can be reduced
Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further?
Stretching exercises may reduce risk of pre-eclampsia during pregnancy
Stretching exercises may be more effective at reducing the risk of preeclampsia than walking is for pregnant women who have already experienced the condition and who do not follow a workout routine, according to researchers at the University of North Carolina at Chapel Hill School of Nursing.
A new gene trigger for pregnancy disorder identified
The COMT gene - known already for its role in schizophrenia - has been found to play a role in preeclampsia, according to a report in today's advance on-line issue of Nature.
Mothers' high normal blood sugar levels place infants at risk for birth problems
Pregnant women with blood sugar levels in the higher range of normal-but not high enough to be considered diabetes-are more likely than women with lower blood sugar levels to give birth to babies at risk for many of the same problems seen in babies born to women with diabetes during pregnancy, according to a study funded in large part by the National Institutes of Health.
New finding may help explain development of preeclampsia
In a study of pregnant women, those with pregnancy-induced high blood pressure were found to have higher levels of a peptide that raises blood pressure in the pieces of tissue linking mother and fetus, according to researchers at Wake Forest University Baptist Medical Center.
Stop eating for two: obese moms-to-be should gain less weight than currently recommended
Severely obese women should lose weight during pregnancy, while obese women who are pregnant should gain less weight than currently recommended, a Saint Louis University study finds.
Low vitamin D during pregnancy linked to preeclampsia
Vitamin D deficiency early in pregnancy is associated with a five-fold increased risk of preeclampsia.
Disparities in infant mortality not related to race, study finds
The cause of low birth weights among African-American women has more to do with racism than with race, according to a report by an associate professor of pediatrics at the University of Illinois at Chicago.
Pregnancy Nausea/Vomiting May Indicate Lower Risk of Breast Cancer
It may not seem so at the time, but women who suffer through morning sickness during their pregnancies actually may be fortunate.
More Preeclampsia News Articles
 | Pre-eclampsia: Etiology and Clinical Practice Pre-eclampsia is one of the leading causes of death and disability in mothers and babies. Over four million women worldwide will develop the disorder every year. This book, written by an international team of experts, focuses on both the scientific basis of pre-eclampsia and its management. The basic science section contains up-to-date reviews of the most exciting research developments in... |
 | Baby Nathan by Denise Davis Denise Davis, MSW, LSW, was born in Hammond, Indiana, in 1972. She was raised by a single mother since the age of ten when her father died in a tragic accident. Focusing on her academics, she worked hard during her school years and earned a master’s degree in social work from Loyola University in 2002. She currently works in Merrillville, Indiana, providing psychotherapy to children and... |
| Pre-eclampsia: The Facts: The Hidden Threat to Pregnancy (Oxford Medical Publications) by Chris Redman, Isabel Walker Pre-eclampsia is the development of hypertension during pregnancy and the most common and the most potentially serious complication of pregnancy. It affects one out of every ten pregnancies, yet there is little known about the disease. This work informs pregnant women, family practitioners, and midwives of this usually symptomless, but often dangerous condition. It includes several illuminating... | |
| The Insulin Time-bomb: Supplement, A New Dawn by Stoakes Ian | |
| EPH-gestosis (preeclampsia): Etiology, prevention, treatment (Publication - Organisation Gestosis Press) by William B Patterson | |
 | Recurrent Miscarriage And Pre-eclampsia: The Roles Played By The Immune System And Antioxidants by Rhoda Wilson Examines the role of antioxidants & of the immune system in pathogenesis of pre-eclamsia & recurrent... |
| Management of severe pre-eclampsia and eclampsia | |
| Pre-eclampsia: Current Perspectives on Management by Philip N. Baker, John Kingdom | |
| A study in pre-eclampsia and eclampsia with special reference to protein stabilization treatment: From the Department of Obstetrics, School of Medicine, ... and the Elizabeth Steel Magee Hospital by Boyd Harden | |
| Preeclamptic and eclamptic toxemia of pregnancy by Lewis Dexter |
| © 2008 BrightSurf.com |